Diva Marketing Talks Pharma + FDA + Social Media With Fard Johnmar and Steve Woodruff
12/17/2009
Diva Marketing Talks is a live, internet radio (BlogTalkRadio) show. 30 minutes. 2 maybe 3 guests. 1 topic about social media marketing. Why? To help you understand how to participate in the "new" conversation without getting blown-up. Miss the show? You can pick it up as a podcast or listen on your computer.
On today's Diva Marketing Talks Fard Johnmar, Envision Solutions and Steve Woodruff, Impactiviti, join me to explore how social media impacts healthcare, with a focus on the pharmaceutical industry. In November the FDA held two days of open hearings that began the process of their development of regulation guidelines for Pharma. For any enterprise stepping into the social web can be a challenge. However, for companies in highly regulated industries, especially healhcare, the stakes are high to get it "right."
The Details
December 17, 2009:
Time: 4:00p - 4:30p Eastern/ 3:p - 3:30p Central/ 2:00p -2:30p Mountain/ 1:00p -1:30p Pacific
Call-in Guest Number: 718.508.9924
Fard Johnmar, M.A., founder of Envision Solutions, has extensive experience in the healthcare marketing communications arena. He has developed and implemented programs for numerous major global and domestic pharmaceutical companies, nonprofits, medical associations and government organizations. Pfizer Inc., Eli Lilly and Company, the Centers for Disease Control and Prevention, Novartis Pharmaceuticals and the International Society on Hypertension in Blacks are just a few of the organizations he has completed engagements with.
Mr. Johnmar has special expertise in cardiovascular disease, mental health,infectious disease, oncology, social media communications, public health and health policy. He holds a Master of Arts degree from New York University's well-regarded Gallatin School of Individualized Study in communications and health policy. He completed his undergraduate degree at Amherst College where he earned a B.A. in jazz ethnomusicology with additional concentrations in pre-medical studies and political science.
Mr. Johnmar writes regularly on healthcare marketing, policy and related subjects for Know More Media (KMM), a leading global business blogging network and other publications. His blog on KMM, HealthCareVox, was recognized as one of the world's top 50 English-language health blogs by edrugsearch.com. Follow Fard on Twitter.
Steve Woodruff is President of Impactiviti, a pharma network advocating new on-line solutions for communications, and "matchmaking" pharmaceutical clients with best-in-class vendor/providers. Steve has over 23 years of experiences in the life sciences arena, and is a well-respected thought leader in the social media field.
Steve has rich experience consulting with numerous pharmaceutical clients (such as Pfizer, Wyeth, Novartis, J&J, Abbott, Takeda, Sanofi-Aventis, Daiichi Sankyo, and many others) on training and marketing solutions, including technology platforms and global applications. Having consulted on the design and implementation of many types of learning initiatives (virtual universities, pre-launch training, printed modules, on-line tutorials, product portals, assessments, webcasts, etc.) for a wide variety of companies, Steve brings a broad perspective to clients as new training and marketing activities are planned.
Steve contributes to the Small Business Branding blog, Marketing Profs Daily Fix, and was recently featured in an article on Better Branding in TheStreet.com. Steve has also launched several on-line portals with aggregated content feeds from the blogging community; PharmaCentral, the Marketing Bloggers portal, and BrandingWire. He has contributed to two recently published “group-authored” books, Age of Conversation and Not Quite What I Was Planning. His branding/marketing/social media blog is called StickyFigure. Follow Steve on Twitter.
In The Diva Bag
Complement of Fard Johnsmar
1. Understand what you face: Pharma companies should understand how e-patients feel about them journeying into the social media space. According to a national survey we recently conducted, they aren't too happy about pharma communicating with them via social media.
However, drug firms may be able to improve e-patient perceptions by providing them with what they want: the straight facts about medicines and valuable information about the conditions they or their loved ones face.
2. Remember, this is Washington: A lot of the commentary I've seen focusing on the FDA hearings deals with the mechanics of Internet promotion and how pharmaceutical companies are being restrained from participating fully.
However, people have to remember that the FDA is not just going to listen to industry insiders when developing policy. They have to deal with Congress and very active and vocal patient/consumer activists who will have a lot to say about the regulations the FDA releases. Back in the 1990s when FDA decided to approve more robust DTC marketing, many said that the agency went too far.
Now, we have the Internet, which is some ways, is a much more powerful and pervasive medium than television. We have to remember that FDA is being pushed in many different directions. We may get regulations, but we may not like what the FDA does.
In addition, we have an article on our new knowledge community, Living the Path, summarizing the FDA's changing regulatory stance and how it impacts pharma and health companies.
Read More:
From Steve Woodruff: Social RX: A Resource Page
From Diva Marketing on the Power to the ePatient
